Delayed versus immediate surgical intervention and prostate cancer outcome - Wikidata - wikimedia - TriplyDB

Delayed versus immediate surgical intervention and prostate cancer outcome

Delayed versus immediate surgical intervention and prostate cancer outcome

http://www.wikidata.org/entity/Q36336991

about

Outcomes of localized prostate cancer following conservative management Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.Best of the 2007 AUA Annual Meeting: Highlights from the 2007 Annual Meeting of the American Urological Association, May 19-24, 2007, Anaheim, CA.Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.Contemporary trends in low risk prostate cancer: risk assessment and treatment Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.A multi-institutional evaluation of active surveillance for low risk prostate cancer.Measuring illness uncertainty in men undergoing active surveillance for prostate cancer Diet and prostate cancer prevention.Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.Active surveillance for the management of localized prostate cancer: Guideline recommendations Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable-risk prostate cancer undergoing active surveillance Watchful waiting and quality of life among prostate cancer survivors in the Physicians' Health Study.Selective detection of histologically aggressive prostate cancer: an Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial.Active surveillance for prostate cancer: an underutilized opportunity for reducing harm.Role of active surveillance in the management of localized prostate cancer.Quality of life in men undergoing active surveillance for localized prostate cancer.Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device Prostate cancer mortality following active surveillance versus immediate radical prostatectomy.Many young men with prostate-specific antigen (PSA) screen-detected prostate cancers may be candidates for active surveillance.Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.African American men with very low-risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy Association between number of prostate biopsies and patient-reported functional outcomes after radical prostatectomy: implications for active surveillance protocols.Timing of curative treatment for prostate cancer: a systematic review.Active surveillance or active treatment in localized prostate cancer?Pro-prostate-specific antigen measurements in serum and tissue are associated with treatment necessity among men enrolled in expectant management for prostate cancer.The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails.Modeling grade progression in an active surveillance study.Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.Is extended and saturation biopsy necessary?Is there an optimal management for localized prostate cancer?Screening, risk assessment, and the approach to therapy in patients with prostate cancer.Active surveillance for low-risk prostate cancer: an update.The current status of active surveillance for prostate cancer.

P2860

Q24647380-AAA51798-9485-4C37-B696-AEF8FA2C9CD7 Q27308897-3EDB53BD-8DEA-427F-B7E8-5CE3A9994210 Q33302509-E1FD5F14-4F7F-4F08-979D-126D3171200F Q33379156-656EEAED-A3D0-494C-A63A-DCFE770C3C85 Q33702311-A1AC8E1F-2247-4DE0-9B4F-26F20D21B033 Q34004995-072C4777-EA73-43B2-993C-E6E938AB5EDF Q34151167-D9CE6833-87F3-4535-98AD-33DC11FFF885 Q34330041-573D355A-9B3A-4C3D-B26A-F23728E2B568 Q34406115-02D71F37-5C45-4401-B624-3610CC3D4419 Q34541484-7B05B86E-444A-4B7D-B109-8737CF49D9E8 Q34761875-C915106F-8BA1-436A-B76C-E12ECF6355DA Q35002417-3731DA92-9725-4069-B534-FB43FCE3A450 Q35322578-0AA56FE2-237E-4722-A086-E3EC59C0F13D Q35725546-8CBE05F2-CBD7-496D-B342-BF6BB3332615 Q35966831-18773E07-CF0B-4B7B-917A-167D72C25BE7 Q35991695-A6C7108E-2F47-4485-A934-C119B775AF7D Q36378954-EA84951D-3D9B-4F45-BD3F-1948BD41477E Q36421154-0903B654-7555-40E8-A566-D2E95DF9F99F Q36520443-25CFB4F6-6FE4-4116-961D-258566C0E98A Q36520452-AD624075-E6E2-494C-9E55-D3A363E99179 Q36520543-91F61D16-C9FB-43CE-ABA3-038AF3AD3C2B Q36579232-65C419BE-8ACA-4B04-9151-F9DBE32A5987 Q36706936-74627DDC-4371-4AE0-96D1-9F8D6F2FEBC9 Q36798276-DE475922-5245-467A-A8E2-A991A0C047A9 Q37025434-23360F55-EFAA-44BB-909F-D89F68BF41F6 Q37085854-15CF882A-C359-49D7-8D34-92C0FAADF841 Q37120344-D3F8DB54-BBC2-4BEF-A24D-E61F32B99952 Q37191405-074168E4-B803-4EF9-A942-7E3CE7DF7DE3 Q37201922-2AC6F915-90AC-4A5D-BCF6-BA35C86366F8 Q37246880-3070B9A1-1A1B-4613-A07C-0472C1EBAC76 Q37456021-6C58061B-9863-4F7F-B9E5-AED814EF2EAD Q37592409-72139EB2-79B3-48BA-8AEC-6F4001113868 Q37598429-7A4656B4-4DE2-4DCD-A49B-3A03352D4228 Q37638830-9A215BD6-029A-4024-9617-8A3315538ADD Q37685652-947B5158-F98F-41F9-AEA8-6134A69C70F2 Q37736544-0EB139B3-146A-4363-9498-47C84EEE8A07 Q37780107-418803A1-63A6-435C-8058-96F156B9160D Q37801615-AEEE1448-7DAB-4945-9F90-84EEBF413CA2 Q37868926-21E4314D-E2AC-4F54-8DF6-D79C196E748A Q38018211-FF241F03-621F-4D8B-9CEB-E5FCD6137776

P2860

Delayed versus immediate surgical intervention and prostate cancer outcome

http://www.wikidata.org/entity/Q36336991

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Delayed versus immediate surgical intervention and prostate cancer outcome

@ast

Delayed versus immediate surgical intervention and prostate cancer outcome

@en

type

label

Delayed versus immediate surgical intervention and prostate cancer outcome

@ast

Delayed versus immediate surgical intervention and prostate cancer outcome

@en

prefLabel

Delayed versus immediate surgical intervention and prostate cancer outcome

@ast

Delayed versus immediate surgical intervention and prostate cancer outcome

@en

P1433

Q36336991-1587BDE6-BA6E-4221-83CA-6EEF74860A9A

P1476

Q36336991-A091D078-7C6E-4CB8-AD51-2E5BC0A589D0

P2093

Q36336991-010D8678-AE15-4CD2-854E-99EA997677EF

Q36336991-1B997C57-D6C8-4690-94C2-E2BCCC1561F6

Q36336991-1BE2B6A5-BB43-43AE-9F8C-281C6AC0F14D

Q36336991-2EB4FDA2-CDBB-4DA4-A6B1-D5F81961BEFB

Q36336991-5F29D9FD-3D1A-487B-B372-EAA9F17C228C

P2860

Q36336991-1403DEA0-6EB0-4608-A531-A967D693F221

Q36336991-5C15E5C7-A247-49E2-A87C-DBD54605EBD0

Q36336991-76F64BFE-A113-40AA-8109-C335D44D3B52

Q36336991-A2212ECF-81BB-493A-9DDF-EAD3C1ADAC1D

Q36336991-B8A68202-D39D-4066-ABBC-E1B251D6F02F

Q36336991-CFBED8CC-92B8-4967-9D12-0677466BF9D9

Q36336991-D8DC2DFE-75B1-488C-9EAF-E92451C908B0

Q36336991-DD9566B3-F132-4AF6-9045-3466381AB9BF

Q36336991-DE3603EF-CC8C-4234-808B-8AE1CB89291A

P304

Q36336991-AAABAE16-3DB0-4AE4-B265-8743AAE390BA

P31

Q36336991-878A7122-BE40-42A2-BA4A-69F9FE43C424

P356

Q36336991-FFDD5D07-B529-4170-8684-ADE9844C60A5

P407

Q36336991-45AB3DB3-522F-409C-A440-1852C2AA5B7C

P433

Q36336991-38E132BB-78F9-41C3-8729-92CD2F63B906

P478

Q36336991-D829D46B-ADA0-422F-9A47-C6CF04CBB7C7

P577

Q36336991-6746CFDB-D699-48C7-82A3-50E87DC4E527

P5875

Q36336991-67780C1C-5EBC-499E-92CD-BF5BD0B9549C

P698

Q36336991-29DFD10D-4E4B-4D11-8269-A3D3A4600082

P932

Q36336991-9FA4A80E-3C34-43ED-A39C-C4482DF9BEA0

P356

P1433

Journal of the National Cancer Institute

P1476

Delayed versus immediate surgical intervention and prostate cancer outcome

@en

P2093

Bruce J Trock

http://www.w3.org/2001/XMLSchema#string

Christopher Warlick

http://www.w3.org/2001/XMLSchema#string

H Ballentine Carter

http://www.w3.org/2001/XMLSchema#string

Jonathan I Epstein

http://www.w3.org/2001/XMLSchema#string

Patricia Landis

http://www.w3.org/2001/XMLSchema#string

P2860

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

Radical prostatectomy versus watchful waiting in early prostate cancer.

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

Lead time associated with screening for prostate cancer.

An analysis of men with clinically localized prostate cancer who deferred definitive therapy.

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

P304

355-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ072

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7269641

http://www.w3.org/2001/XMLSchema#string

P698

16507832

http://www.w3.org/2001/XMLSchema#string

P932

3477641

http://www.w3.org/2001/XMLSchema#string